Cor Vasa 2006, 48(10):345-350 | DOI: 10.33678/cor.2006.112

Hypertension and coronary heart disease. Is there a J-curve for diastolic blood pressure?

Jiří Widimský
Klinika kardiologie, Institut klinické a experimentální medicíny, Subkatedra kardiologie IPVZ, Praha, Česká republika

While some studies pointed to the possible existence of a J curve of diastolic blood pressure, other studies did not confirm such a relationship.
A recent retrospective analysis of INVEST involving 22,576 patients with hypertension and coronary heart disease has shown the risk of the primary endpoint had had a J-curve relationship with diastolic blood pressure (BP) peaking at a BP of 119/84 mmHg. A J-curve relationship was particularly obvious between diastolic BP and the risk of fatal and nonfatal myocardial infarction. A J-curve relationship for the risk for fatal and non-fatal stroke was only suggested. Compared with the incidence of myocardial infarction in patients with a diastolic BP of 70-90 mmHg, that in patients with a diastolic BP of 60-70 mmHg (on therapy) was double, and even triple in individuals with a diastolic BP < 60 mmHg.
These retrospective findings made in CHD patients receiving antihypertensive therapy do not document a causal relation nor do they allow concluding that the excess fall in diastolic BP caused by antihypertensive therapy results in excess morbidity and mortality.
Regrettably, there is no prospective randomized study evaluating the effect of antihypertensive therapy aimed at reaching low diastolic BP levels, i. e., decreases below 80, 70, and 60 mmHg. Such a study would be ideally conducted in patients with isolated systolic hypertension.
Though controversial, the above findings reported in this review suggest low diastolic BP levels may be associated with an increased cardiovascular risk.
Of the three potential interpretations of a J-curve relationship between diastolic BP and coronary events, the most likely one is highlighting the fact an increased risk is present particularly in elderly patients with isolated systolic hypertension.
There has been no study to date demonstrating a decrease in systolic BP in the elderly within a range of 140-159 mmHg has a beneficial effect on morbidity and mortality, with a goal systolic BP level below 140 mmHg. The recommendations of goal levels < 140 mmHg even in the elderly are particularly based on the observational studies.
It is our impression that, given the current controversial J-curve data, and the relationship between diastolic BP and coronary events, it is appropriate to give utmost attention to patients with isolated systolic hypertension whose diastolic BP falls below 65 mmHg while receiving therapy. In such situations, one should not insist on reaching goal systolic BP levels. This should presumably apply mostly to elderly patients with coronary heart disease.

Keywords: Diastolic blood pressure-related J-curve; Hypertension and CHD; Isolated systolic hypertension

Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J. Hypertension and coronary heart disease. Is there a J-curve for diastolic blood pressure? Cor Vasa. 2006;48(10):345-350. doi: 10.33678/cor.2006.112.
Download citation

References

  1. Stewart IMG. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979;1:861-5. Go to original source... Go to PubMed...
  2. Coope J, Warrander TS. Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986;293:1145-51. Go to original source... Go to PubMed...
  3. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and possible harm of lowering high blood pressure. Lancet 1987;1:581-4. Go to original source... Go to PubMed...
  4. Walter PC, Isles CG, Lever AF, et al. Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens 1988;2:7-10. Go to PubMed...
  5. Fletcher A, Beevers DGH, Bulpitt CJ, et al. The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Comparing Project (DHCCP). J Hum Hypertens 1988; 2:11-5. Go to PubMed...
  6. Samuelsson OG, Wilhelmsen LW, Pennert KM, et al. The J-shaped relation between coronary heart disease and achieved blood pressure level in treated hypertensives. J Hypertens 1990;8:547-55. Go to original source... Go to PubMed...
  7. Farnett L, Mulrow CD, Linn WD, et al. The J-curve phenomenon and the treatment of hypertension. JAMA 1991;265:489-95. Go to original source... Go to PubMed...
  8. McCloskey LW, Psaty BM, Koepsell TD, Aagaard GN. Level of blood pressure and risk of myocardial infarction among treated hypertensives patients. Arch Intern Med 1992;152:473-6. Go to original source...
  9. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;20:395-401. Go to original source... Go to PubMed...
  10. Miller JA, Lever AF. Implications of pulse pressure as a prediktor of cardiac risk in patients with hypertension. Hypertension 2000;36:907-18. Go to original source... Go to PubMed...
  11. Benetos A. Pulse pressure and cardiovascular risk. J Hypertens 1999;17 Suppl 5:S21-S24.
  12. Domanski M, Mitchell G, Pfeffer M, et al. MRFIT Research Group. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 2002; 287:2677-83. Go to original source... Go to PubMed...
  13. Prospective Studies Collaborators. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. Go to original source... Go to PubMed...
  14. Staessen J, Bulpitt C, Clement D, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the elderly. Br Med J 1989;298:1552-6. Go to original source... Go to PubMed...
  15. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265: 3255-64. Go to original source... Go to PubMed...
  16. Vaccarino V, Berger AK, Abramson J, et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 2001;88:980-6. Go to original source... Go to PubMed...
  17. Somes GW, Pahore M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999;159:2004-9. Go to original source... Go to PubMed...
  18. Franklin SS, Khan SA, Wang ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999;100: 354-60. Go to original source... Go to PubMed...
  19. Staessen JA, Gasowski J, Wang JG, et al. Risk of untreated and treated isolated systolic hypertension in the elderly. Lancet 2000;355:865-72. Go to original source... Go to PubMed...
  20. Hansson L, Zanchetti A, Carruthers JG, et al. for the HOT Study Group. Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351: 1755-62. Go to original source... Go to PubMed...
  21. Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke and total mortality. The Cardiovascular Health Study. Arch Intern Med 2001;161:1183-92. Go to original source... Go to PubMed...
  22. Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fraction. Lancet 1992;340:1173-8. Go to original source... Go to PubMed...
  23. Kannel WB, Wilson PWF, Nam B-H, D'Agostino RB. A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol 2004;148:16-26. Go to original source... Go to PubMed...
  24. Boutitie F, Gueyffier F, Pocock S, et al. J-shaped relationship between blood pressure and mortality in hypertensives patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002;136: 438-48. Go to original source... Go to PubMed...
  25. Nissen SE, Tuscu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT Study: A randomized controlled trial. JAMA 2004;292:2217-26. Go to original source... Go to PubMed...
  26. Messerli FH, Mancia G, Conti R, et al. J-curve in hypertension and coronary artery disease. Am J Cardiol 2005;95:160 (Letter to editor).
  27. Messerli FH, Mancia G, Conti R, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006;144:884-93. Go to original source... Go to PubMed...
  28. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet 2004;364: 1684-9. Go to original source... Go to PubMed...
  29. Chaudhry SI, Krumholz HM, Foody JM. Systolic hypertension in older persons. JAMA 2004;292:1074-80. Go to original source... Go to PubMed...
  30. Cushman WC, Materson BJ, Williams DW, et al. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled, trial. Hypertension 2001;38:953-7. Go to original source... Go to PubMed...
  31. Kaplan NM. Kaplan's Clinical Hypertension. 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2006:518.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.